Filed: 2/12/2026ACC: 0001622627-26-000011
📋 What this filing means
ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 42 equity positions with a total reported market value of $284.53M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
42
Positions
$284.53M
Total AUM (reported)
45.86M
Total Shares
Allocation by class
COM$134.35M47.2%
COM NEW$122.47M43.0%
SHS NEW$13.83M4.9%
PUT$9.26M3.3%
COM CL A$2.12M0.7%
ORDINARY SHARES$1.70M0.6%
CALL$807.9K0.3%
Portfolio Concentration
Top 3$73.65M25.9%
4–10$99.09M34.8%
11–25$100.12M35.2%
Rest$11.67M4.1%
Top 3 weight
25.9%
Top 10 weight
60.7%
Voting Authority Distribution
Total shares with voting rights: 45.86M
Sole
Full voting authority
45.86M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole42
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings42
Rows:
DELCATH SYSTEMS, INC.
SOLEShares3.30M
TypeSH
Market value$33.00M
11.60%
Sole
3.30M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.40M
TypeSH
Market value$20.52M
7.21%
Sole
3.40M
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares2.61M
TypeSH
Market value$20.12M
7.07%
Sole
2.61M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDGS INC
SOLEShares2.11M
TypeSH
Market value$16.58M
5.83%
Sole
2.11M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares450K
TypeSH
Market value$14.00M
4.92%
Sole
450K
Shared
0.00
None
0.00
MEDIWOUND LTD
SOLEShares749.05K
TypeSH
Market value$13.83M
4.86%
Sole
749.05K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares1.79M
TypeSH
Market value$13.81M
4.85%
Sole
1.79M
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares1.41M
TypeSH
Market value$13.71M
4.82%
Sole
1.41M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares1.04M
TypeSH
Market value$13.60M
4.78%
Sole
1.04M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares1.66M
TypeSH
Market value$13.56M
4.77%
Sole
1.66M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares690K
TypeSH
Market value$12.61M
4.43%
Sole
690K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares300K
TypeSH
Market value$12.46M
4.38%
Sole
300K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares195.04K
TypeSH
Market value$12.39M
4.36%
Sole
195.04K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares2.61M
TypeSH
Market value$10.42M
3.66%
Sole
2.61M
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares750K
TypeSH
Market value$10.04M
3.53%
Sole
750K
Shared
0.00
None
0.00
PROFOUND MEDICAL CORP
SOLEShares1.07M
TypeSH
Market value$8.41M
2.96%
Sole
1.07M
Shared
0.00
None
0.00
INSPIREMD INC
SOLEShares3.91M
TypeSH
Market value$6.95M
2.44%
Sole
3.91M
Shared
0.00
None
0.00
Ocular Therapeutix, Inc
SOLEShares400K
TypeSH
Market value$4.86M
1.71%
Sole
400K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares215.87K
TypeSH
Market value$4.34M
1.53%
Sole
215.87K
Shared
0.00
None
0.00
TALPHERA INC
SOLEShares3.58M
TypeSH
Market value$4.08M
1.43%
Sole
3.58M
Shared
0.00
None
0.00
MYOMO INC
SOLEShares3.84M
TypeSH
Market value$3.49M
1.23%
Sole
3.84M
Shared
0.00
None
0.00
INVESCO QQQ TR
SOLEShares450K
TypeSH
Market value$3.03M
1.06%
Sole
450K
Shared
0.00
None
0.00
POLYPID LTD
SOLEShares696.56K
TypeSH
Market value$3.02M
1.06%
Sole
696.56K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares730.49K
TypeSH
Market value$2.12M
0.74%
Sole
730.49K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares510K
TypeSH
Market value$1.89M
0.66%
Sole
510K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DELCATH SYSTEMS, INC.SOLE | COM NEW | 3.30M | SH | $33.00M 11.60% | 3.30M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.40M | SH | $20.52M 7.21% | 3.40M | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 2.61M | SH | $20.12M 7.07% | 2.61M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDGS INCSOLE | COM | 2.11M | SH | $16.58M 5.83% | 2.11M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 450K | SH | $14.00M 4.92% | 450K | 0.00 | 0.00 |
MEDIWOUND LTDSOLE | SHS NEW | 749.05K | SH | $13.83M 4.86% | 749.05K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 1.79M | SH | $13.81M 4.85% | 1.79M | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 1.41M | SH | $13.71M 4.82% | 1.41M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 1.04M | SH | $13.60M 4.78% | 1.04M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 1.66M | SH | $13.56M 4.77% | 1.66M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 690K | SH | $12.61M 4.43% | 690K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 300K | SH | $12.46M 4.38% | 300K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 195.04K | SH | $12.39M 4.36% | 195.04K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 2.61M | SH | $10.42M 3.66% | 2.61M | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 750K | SH | $10.04M 3.53% | 750K | 0.00 | 0.00 |
PROFOUND MEDICAL CORPSOLE | COM NEW | 1.07M | SH | $8.41M 2.96% | 1.07M | 0.00 | 0.00 |
INSPIREMD INCSOLE | COM | 3.91M | SH | $6.95M 2.44% | 3.91M | 0.00 | 0.00 |
Ocular Therapeutix, IncSOLE | COM | 400K | SH | $4.86M 1.71% | 400K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 215.87K | SH | $4.34M 1.53% | 215.87K | 0.00 | 0.00 |
TALPHERA INCSOLE | COM NEW | 3.58M | SH | $4.08M 1.43% | 3.58M | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 3.84M | SH | $3.49M 1.23% | 3.84M | 0.00 | 0.00 |
INVESCO QQQ TRSOLE | PUT | 450K | SH | $3.03M 1.06% | 450K | 0.00 | 0.00 |
POLYPID LTDSOLE | COM | 696.56K | SH | $3.02M 1.06% | 696.56K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 730.49K | SH | $2.12M 0.74% | 730.49K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | PUT | 510K | SH | $1.89M 0.66% | 510K | 0.00 | 0.00 |
Page 1 of 2